Reversible Splenial Lesion Syndrome and Multisystem Inflammatory Syndrome Findings in a Child with SARS-COV-2 Infection

Abstract

Reversible splenial lesion syndrome (RESLES) is a transient lesion in the splenium of the corpus callosum. Etiology includes infections, malignancies, drugs, metabolic disorders, trauma, etc. We reported radiological features of a child with RESLES and multisystem inflammatory syndrome (MIS-C) with severe acute respiratory syndrome COVID-19 (SARS-CoV-2) infection in a 11-year-old boy. Diagnosis of SARS COV-2 infection was based on the detection of antiSARS-CoV-2 IgG and IgM in his serum.

Keywords

COVID-19 - multisystem inflammatory syndrome - reversible splenial lesion syndrome - cytotoxic lesions of the corpus callosum

Publication History

Received: 15 February 2022

Accepted: 15 February 2022

Article published online:
11 July 2022

• References

• 1 Starkey J, Kobayashi N, Numaguchi Y, Moritani T. Cytotoxic lesions of the corpus callosum that show restricted diffusion: mechanisms, causes, and manifestations. Radiographics 2017; 37 (02) 562-576
• 2 Bektaş G, Akçay N, Boydağ K, Şevketoğlu E. Reversible splenial lesion syndrome associated with SARS-CoV-2 infection in two children. Brain Dev 2021; 43 (02) 230-233
• 3 Chen WX, Liu HS, Yang SD. et al. Reversible splenial lesion syndrome in children: retrospective study and summary of case series. Brain Dev 2016; 38 (10) 915-927
• 4 Abdel-Mannan O, Eyre M, Löbel U. et al. Neurologic and radiographic findings associated with COVID-19 infection in children. JAMA Neurol 2020; 77 (11) 1440-1445
• 5 Kontzialis M, Soares BP, Huisman TAGM. Lesions in the splenium of the corpus callosum on MRI in children: a review. J Neuroimaging 2017; 27 (06) 549-561
• 6 LaRovere KL, Riggs BJ, Poussaint TY. et al; Overcoming COVID-19 Investigators. Neurologic involvement in children and adolescents hospitalized in the United States for COVID-19 or multisystem inflammatory syndrome. JAMA Neurol 2021; 78 (05) 536-547